logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
陆

陆颖 (Ying Lu)

宁波大学副教授
H指数:13
被引数:859

个人简介

"女，江苏南通人，博士"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults

年龄作为核心疾病修饰因子：青少年和年轻成人原发性血小板增多症在临床、分子和预后方面的不同景观

British Journal of Haematology
IF3.8
2026-09-060
PRE
Jia Li; Bingbing Wen; Xiudi Yang; Honglan Qian; Binbin Lai; Xiao Yan; Xiaojing Bao; Mei Zhou; Zhaohao Huang; Yongming Xia; Li Huang; Gang Zhang; Feng Zhu; Li Zhang; Yanping Shao; Guoli Yao; Ying Lu; Yanxia Han; Muqing He; Dan Cao; Huyi Lei; Qinli Tang; Yu Chen; Weiying Feng; Meiwei Hu; Lifeng Wang; Hangping Ge; Xianghua Lang; Lihong Cao; Sai Chen; Hui Zhou; Huiqi Zhang; Xiujie Zhou; Hongyan Tong; Jie Jin; Jian Huang
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial

低剂量芦可替尼在单倍体造血干细胞移植中预防移植物抗宿主病：一项多中心、开放标签、随机对照、III期临床试验

Lancet Haematology
IF17.7
2026-07-300
PRE
Hengwei Wu; Wenming Shi; Zhuoyue Shi; Yi Luo; Jian Yu; Weijie Cao; Junjie Cao; Xiaojun Xu; Xiaoxia Hu; Ying Lu; Huarui Fu; Lizhen Liu; Xiaoyu Lai; Luxin Yang; Yishan Ye; Congxiao Zhang; Jimin Shi; He Huang; Yanmin Zhao
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group

新诊断KMT2Ar AML的特征和预后意义：ECLA小组的多中心研究

American Journal of Hematology
IF9.9
2026-05-260
PRE
Jiajia Pan; Chunmei Fu; Qing Ling; Ying Lu; Yifen Shi; Yunxiang Zhang; Shaoyuan Wang; Chunyan Ji; Shenxian Qian; Zhenqi Huang; Zheng Ge; Jingcheng Zhang; Guifang Ouyang; Chenghao Jin; Quanyi Lu; Li Huang; Hongwei Kong; Yu Zhu; Zhiling Yan; Debin Liu; Huawei Jiang; Nianci Chen; Xiangjie Lin; Yile Zhou; Yi Zhang; Xia Li; Hongyan Tong; Jie Jin; Suning Chen; Huafeng Wang; East China Leukemia Alliance
Successful Treatment of Primary Poor Graft Function After Haploidentical Hematopoietic Stem Cell Transplantation With Low-Dose Decitabine Followed by Donor Lymphocyte Infusion and Eltrombopag

异基因造血干细胞移植后原发性移植物功能不良的低剂量地西他滨治疗成功，随后进行供者淋巴细胞输注和艾曲波帕治疗

Cancer Medicine
IF3.1
2026-03-150
OAAI
Jiaojiao Yuan; Junjie Cao; Peipei Ye; Tiantian Wang; Dong Chen; Shuangyue Li; Renzhi Pei; Juntao Zhang; Ying Lu
Venetoclax and Homoharringtonine-Based Therapy Exhibited a Striking Response in Refractory/Relapsed Early T-Cell Precursor Acute Lymphoblastic Leukemia

Venetoclax和Homoharringtonine为基础的治疗方案在难治/复发性早期T细胞前体急性淋巴细胞白血病中表现出显著疗效。

MEDCOMM
IF10.7
2025-12-120
OAAI
Zhang, Xiang; Zhou, Hongsheng; Mao, Liping; Lou, Yinjun; Shen, Lijing; Lu, Ying; Liu, Zhenfang; Tong, Xiuzhen; Zhang, Aiping; Liu, Tingbo; Zhang, Na; Ye, Xingnong; Wei, Juying; Luo, Meihong; Wang, Shaoyuan; Bai, Qingxian; Hou, Jian; Liu, Qifa; Tong, Hongyan; Jin, Jie; Yu, Wenjuan
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms

TP53变异和胚系突变对急性髓系白血病和骨髓增生异常肿瘤异基因造血干细胞移植结局的影响

Leukemia
IF13.4
2025-07-140
PRE
Yeqian Zhao; Weijie Cao; Jimin Shi; Yang Cao; Ying Lu; Yi Luo; Guifang Ouyang; Lieguang Chen; Jianping Lan; Xiaolu Song; Yi Chen; Li Yu; Jian Yu; Xiaoyu Lai; Lizhen Liu; Huarui Fu; Yishan Ye; Luxin Yang; Xiaodong Mo; Xiaoxia Hu; He Huang; Yanmin Zhao
Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model
CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2024-11-220
OAAI
Zeng, Tian; Yang, Xiudi; Wang, Yi; Wu, Dijiong; Feng, Weiying; Lu, Ying; Zhu, Xiaoqiong; Liu, Lirong; Zhou, Mei; Zhang, Li; Shao, Yanping; Qian, Honglan; Zhu, Feng; Chen, Yu; Cao, Dan; Huang, Li; Feng, Xiaoning; Chen, Lili; Zhang, Gang; Le, Jing; Zhu, Weiguo; Xia, Yongming; Han, Yanxia; Jia, Yongqing; Tian, Guoyan; Zhou, Hui; Xu, Linjuan; Yin, Xiufeng; Tang, Qinli; Zhang, Yuefeng; Yao, Guoli; Lang, Xianghua; Zhang, Kaifeng; Zhou, Xiujie; Guo, Junbin; Tu, Jinming; Zhao, Jianzhi; Wu, Gongqiang; Zhang, Huiqi; Wu, Xiao; Luo, Qiulian; Cao, Lihong; Chu, Binbin; Jiang, Wei; Wu, Haiying; Huang, Liansheng; Hu, Meiwei; He, Muqing; Zhu, Jingjing; Tong, Hongyan; Jin, Jie; Huang, Jian
A Prognostic Model Guiding Treatment Switch for 5-Year Deep Molecular Response in Chronic Myeloid Leukemia Patients Receiving Initial Imatinib: An Extensive, Multi-Center, Retrospective Study

一个用于指导初始接受伊马替尼治疗的慢性髓系白血病患者在5年内实现深度分子缓解的治疗转换的预后模型：一项广泛的多中心回顾性研究

BLOOD
IF23.1
2024-11-050
PRE
Zeng, Tian; Yang, Xiudi; Wang, Yi; Wu, Dijiong; Feng, Weiying; Lu, Ying; Wang, Huafeng; Huang, Jian
Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin's Lymphoma: Real-World Data in Chinese Population

Axicabtagene Ciloleucel（Axi-cel）治疗复发/难治性非霍奇金淋巴瘤的疗效与安全性：中国人群真实世界数据

BLOOD
IF23.1
2024-11-050
PRE
Yan, Zixun; Zou, Dehui; Qian, Wenbin; Lu, Ying; Li, Yuhua; Ji, Dongmei; Zhu, Xiaojian; Mei, Heng; Li, Ping; Qu, Changju; Zhang, Lei; Zhou, Keshu; Jing, Hongmei; Niu, Ting; Ji, Chunyan; Li, Lanfang; Yang, Hua; Li, Fei; Wang, Wei; Xu, Kailin; Zhao, Jinghua; Wu, Depei; Hu, Yu; Zhao, Weili
Azacitidine, Homoharringtonine and Cytarabine Combined with Granulocyte Colony-Stimulating Factor As Frontline Treatment for Older Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase III Study in China

阿扎胞苷、高三尖杉酯碱和吉西他滨联合粒细胞集落刺激因子作为老年急性髓系白血病患者的初始治疗方案：一项在中国进行的预期性、多中心、单臂III期研究

BLOOD
IF23.1
2024-11-050
PRE
Ma, Yafang; Zhang, Xiang; Hou, Jian; Shen, Lijing; Li, Fei; Kong, Fancong; Lu, Ying; Li, Guowei; Jin, Jie; Yu, Wenjuan
Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: multicentre retrospective study

从原发性血小板增多症到原发性血小板增多症后骨髓纤维化早期预测模型的开发和验证: 多中心回顾性研究

ECLINICALMEDICINE
IF10
2024-01-014
OAAI
Xiang, Danhong; Yang, Xiudi; Qian, Honglan; Zhang, Li; Han, Yanxia; Sun, Yongcheng; Lu, Ying; Chen, Yu; Cao, Dan; Hu, Meiwei; Wang, Lifeng; Tang, Qinli; Wu, Dijiong; Tian, Guoyan; Tong, Hongyan; Jin, Jie; Huang, Jian

研究方向

营养成分与神经系统疾病
J
Jie Jin
H 指数:60论文数:1,289被引数:1.8万
X
Xiudi Yang
H 指数:12论文数:66被引数:342
H
Hongyan Tong
H 指数:26论文数:353被引数:2,464
D
De‐Li Cao
H 指数:23论文数:57被引数:2,269
Y
Yong‐Jing Gao
H 指数:52论文数:164被引数:1.0万
J
Jianping Lan
H 指数:10论文数:55被引数:728
H
Huarui Fu
H 指数:12论文数:113被引数:626
Huang He 封面图
Huang He
H 指数:67论文数:1,108被引数:2.2万
张志军 封面图
张志军
H 指数:44论文数:139被引数:7,083
Y
Yanmin Zhao
H 指数:28论文数:277被引数:2,881